Drug
MR 100a 01
MR 100a 01: highest development phase Phase 3, developed by Viatris. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Viatris
Trials
| Drug | Phase | Indication |
|---|---|---|
| MR-100A-01 NCT05139121 | Phase 3 | Contraception |
Latest
No recent events.
Follow MR 100a 01 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.